Drug Database
Back to search

Ireland· IE-PA-PA0822/129/001

Halcion 250 microgram Tablets

A triazolam product containing triazolam, registered in Ireland by Pfizer Healthcare Ireland Unlimited Company. The same ATC class is registered in 9 of our 19 countries.

ATC N05CD05

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedHalcion 250 microgram TabletsATCN05CD05REGISTER NO.IE-PA-PA0822/129/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about triazolamAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Triazolam is registered in 9 of 19 countries.

Countries holding a registration under ATC N05CD05 (triazolam), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 4 of them publish a price we can compare per daily dose
Search triazolam products by name

Triazolam · ATC N05CD05

9 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of triazolam costs, country by country.

Normalised to the WHO defined daily dose (0.25 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Triazolam · price per daily dose (0.25 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Triazolam
Manufacturer
Pfizer Healthcare Ireland Unlimited Company
Country
Ireland (IE)
ATC code
N05CD05
ATC class
Triazolam
Defined daily dose
0.25 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0822/129/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

344 interactions on record for triazolam.

Graded by severity as the source publishes them — 13 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check triazolam against other medicinesHow interaction checks work

Triazolam · interactions on record

344 records

  • 13 severe
  • 146 moderate
  • 32 minor
  • 107 info

Most severe, free to view

  • KetoconazoleH02CA03severe
  • KetoconazoleJ02AB02severe
  • FluconazoleJ02AC01severe
  • Darunavir and cobicistatJ05AR14severe

46 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Triazolam in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All triazolam products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Halcion
  • Belgium · Halcion
  • Germany · Halcion
  • Spain · Halcion
  • Finland · Halcion
  • Italy · Halcion, Songar
  • Lithuania · Halcion
  • Luxembourg · Halcion
  • Latvia · Halcion
  • Portugal · Halcion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b724669b-4312-4b32-896c-e3c843d71a93
GET /v1/drugs/b724669b-4312-4b32-896c-e3c843d71a93?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N05CD",
    "N05CD05"
  ],
  "strength": null,
  "pa_number": "PA0822/129/001",
  "substances": [
    "Triazolam"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "30/09/1977",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about triazolam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console